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Abstract
Background: Asthma and allergy are complex multifactorial disorders, with both genetic and
environmental components determining disease expression. The use of molecular genetics holds
great promise for the identification of novel drug targets for the treatment of asthma and allergy.
Genome-wide linkage studies have identified a number of potential disease susceptibility loci but
replication remains inconsistent. The aim of the current study was to complete a meta-analysis of
data from genome-wide linkage studies of asthma and related phenotypes and provide inferences
about the consistency of results and to identify novel regions for future gene discovery.
Methods: The rank based genome-scan meta-analysis (GSMA) method was used to combine
linkage data for asthma and related traits; bronchial hyper-responsiveness (BHR), allergen positive
skin prick test (SPT) and total serum Immunoglobulin E (IgE) from nine Caucasian asthma
populations.
Results: Significant evidence for susceptibility loci was identified for quantitative traits including;
BHR (989 pedigrees, n = 4,294) 2p12-q22.1, 6p22.3-p21.1 and 11q24.1-qter, allergen SPT (1,093
pedigrees, n = 4,746) 3p22.1-q22.1, 17p12-q24.3 and total IgE (729 pedigrees, n = 3,224) 5q11.2-
q14.3 and 6pter-p22.3. Analysis of the asthma phenotype (1,267 pedigrees, n = 5,832) did not
identify any region showing genome-wide significance.
Conclusion:  This study represents the first linkage meta-analysis to determine the relative
contribution of chromosomal regions to the risk of developing asthma and atopy. Several significant
results were obtained for quantitative traits but not for asthma confirming the increased phenotype
and genetic heterogeneity in asthma. These analyses support the contribution of regions that
contain previously identified asthma susceptibility genes and provide the first evidence for
susceptibility loci on 5q11.2-q14.3 and 11q24.1-qter.
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Background
Asthma is a disease characterised by recurrent respiratory
symptoms, reversible variable airway obstruction, airway
inflammation and increased bronchial hyper-responsive-
ness [1]. Estimates suggest that 100–150 million people
worldwide have asthma. Atopy is a predisposition
towards the development of immediate hypersensitivity
against common environmental antigens. Atopy and
asthma are closely related, however they are not inter-
changeable. Most asthmatic individuals are atopic but
atopic individuals may not have asthmatic symptoms.
Asthma and atopic disease show strong familial aggrega-
tion and heritability estimates vary between 36–79% [2].
A greater understanding of the genetic basis of asthma and
atopy holds great promise for the identification of novel
therapeutic targets.
Linkage analysis using short tandem repeats or microsat-
ellites to follow the transfer of genetic information
between generations has been used to identify chromo-
somal regions that potentially contain asthma and atopy
susceptibility genes. Commonly sub-phenotypes of clini-
cal relevance are used including; elevated total Immu-
noglobulin E (IgE) levels, atopy defined by positive skin
prick test to one or more allergen or elevated specific IgE
and bronchial hyper-responsiveness (BHR) [3]. These
studies have identified linkage on multiple chromosomal
regions e.g. 2q22-33, 5q31.1-33, 6p21.3, 11q13, 12q14.3-
24.1, 13q14, 14q11.2-13 and 19q13; however replication
of linkage findings has been limited [3]. Low statistical
power and the potential for type I and type II errors may
explain these findings. Combining data has the potential
to provide inferences about the consistency of results
across studies and to identify regions that contain asthma
and atopy susceptibility genes.
The aim of the current study was to complete the first
meta-analysis of available genome wide linkage data for
asthma and related traits (asthma per se, BHR, total IgE,
allergen skin prick test response (SPT)) in the Caucasian
population using the Genome Scan Meta Analysis
(GSMA) method [4]. GSMA is a non parametric, rank
based approach and has been used extensively in other
disorders e.g. schizophrenia [5].
Methods
Systematic Literature Search
To identify published studies for inclusion in the GSMA of
asthma and related phenotypes we completed a system-
atic literature review in September 2006. We used
PubMed and the following search string (Asthma OR BHR
OR bronchial hyper responsiveness OR bronchial hyperreactiv-
ity OR AHR OR airway hyper responsiveness OR respiratory
hypersensitivity OR histamine OR slope OR methacholine OR
atopy OR atopic OR dermatitis, atopic OR IgE OR immu-
noglobulin E OR SPT OR skin prick tests OR skin tests) AND
linkage AND genome-scan OR scan OR genome OR genom-
ewide OR genome-wide OR LOD OR microsatellite). Limits
were set on the search including; published in English,
human studies, published 1996–2006 and the exclusion
of reviews. This initial search identified 516 matches of
which 488 were discarded as not containing genome-wide
linkage data. A further eight studies were discarded as they
were in non-Caucasian populations and we wished to
avoid any population stratification issues leaving 20
potential Caucasian studies for inclusion. Genome-wide
linkage analyses for asthma related traits in the Hutterite
Founder population [6] was not included in the current
analyses as limited data was available and the focus of the
present study was Caucasian out-bred populations.
Of the 20 manuscripts identified a further nine were
removed from the analyses for a combination of the fol-
lowing reasons; the study was superseded by another
including the families from the original, LOD score plots
in the manuscript were not labelled and/or unreadable,
no genome-wide data was presented e.g. in the manu-
script describing the positional cloning of ADAM33, link-
age analyses in 460 families for asthma, IgE and BHR
phenotypes were performed but has never been published
in full [7] or the phenotypes studied did not meet our cri-
teria. All authors were contacted and invited to provide
complete datasets.
Phenotype definition and study inclusion/exclusion
There was a large degree of heterogeneity in phenotype
definitions and so these were standardised for inclusion.
Asthma was defined using doctor diagnosis and/or cur-
rently taking asthma medication, however we did include
data from the Dutch population which used an algorithm
based on asthma symptoms, the presence of BHR, revers-
ibility to β2-adrenergic receptor agonist and smoking his-
tory to define asthma [8]. Analyses were completed with
and without the Dutch families. Total IgE levels were ana-
lysed in the genome scans using quantitative data gener-
ated by Pharmacia CAP system [9], Pharmacia IgE EIA
[10], Phadebas PRIST [11] and ELISA techniques [12,13]
which have shown good inter assay correlation [14,15],
therefore all studies were included. Positive skin prick
response to one or more allergen was used as a marker of
atopy and for inclusion in the GSMA. However, allergens
used in each study varied; Dermatphagoides pteronyssi-
nus, mixed grass pollen [9], Dermatphagoides pteronyssi-
nus, Cladosporium herbarum, Alternaria tenuis, timothy
grass, olive, birch, Parieteria judaica, ragweed, Aspergillus,
Blatella Germancia [11], mixed grass and tree pollens,
mixed weeds, Dermatphagoides pteronyssinus, dog, cat, a
mixture of guinea pig and rabbit, horse, Aspergillus fumi-
gatus, Alternaria alternate [10], house dust mite [12], Der-
matphagoides pteronyssinus and 10 others [13] andRespiratory Research 2008, 9:38 http://respiratory-research.com/content/9/1/38
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Dermatphagoides pteronyssinus, D. farinae, dog, cat,
grass mix, pollen and alternaria [16]. BHR was measured
in multiple ways using different provocation stimuli e.g.
histamine or methacholine providing categorical and/or
quantitative analyses. These provocation stimuli have
shown a significant correlation (r = 0.95) in the responses
induced [17], however it is worth noting that this has not
been reproduced in all studies. Studies with BHR data
were included in the GSMA irrespective of the criteria used
in the original manuscript.
Genome Scan Meta Analysis (GSMA)
GSMA was used as it is able to combine linkage data from
studies with different marker sets and analysed by differ-
ent methods including permutated p-values. GSMA was
implemented using GSMA software [4,5,18]. Briefly, the
genome was divided into 120 bins of approximately 30
cM, for each study the maximum evidence for linkage e.g.
LOD score or p-value was identified for each bin and these
bins were then ranked relative to their evidence for linkage
in that study. These ranks were summed across studies
and the summed rank (SR) forms the basis of the test sta-
tistic [4]. An ordered rank (OR) statistic was also gener-
ated which gives a genome wide interpretation of
significance by comparing the n-th highest summed rank
with the distribution of the n-th highest summed ranks
obtained through simulation [5]. We completed an
unweighted and weighted analyses using information
content (√(no. pedigrees × no. markers)) as a weighting
factor.
Statistical Significance
Simulation studies have shown that any bin with a p(SR)
< 0.05 and a p(OR) < 0.05 has a high probability of con-
taining a true susceptibility gene [5]. Applying Bonferroni
correction a p < 0.000417 provides evidence for genome
wide significance for linkage and a p < 0.0083 provides
suggestive evidence for linkage [5].
Results
Data included
The selection criteria and data requests provided eleven
studies of nine Caucasian asthma populations for our
analyses (Table 1) including data from 1,267 pedigrees (n
= 5,832) for asthma (80.2% of pedigrees available in the
public domain or following request, missing 249 [19] and
65 pedigrees [20]), 989 pedigrees (n = 4,294) for BHR
(79.9% of available, missing 249 pedigrees [19]), 1,093
pedigrees (n = 4,746) for SPT (81.5% of available, missing
249 pedigrees [19]) and 729 pedigrees (n = 3,224) for
total IgE (65.9% of available, missing 249 [19], and 129
pedigrees [21]).
Asthma
The weighted asthma analyses did not identify any chro-
mosomal region with a p(SR) and p(OR) < 0.05 (Figure 1
and Table 2). No bin p(SR) met genome wide significance
(p < 0.000417) or suggestive evidence for linkage (p <
0.0083) in these analyses however three regions demon-
strated a p(SR) < 0.05; 6p22.3-p21.1, 10p14-q11.21 and
12q24.31-qter (Table 2). Eight regions met suggestive
linkage criteria in the ordered rank analyses; 1p31.1-
p13.3, 2p12-q22.1, 4p14-q13.3, 7q34-qter, 12pter-p12,1,
12p12.1-p11.21, 14q32.12-qter, 17pter-p12 and 20pter-
p12.3 (Table 2). Analyses of the asthma phenotype using
unweighted GSMA generated similar findings to the
weighted analyses (Figure 2). To confirm that the inclu-
sion of the Dutch linkage data for the asthma phenotype
(defined by algorithm) had not confounded the analyses
we completed GSMA without these data focusing on doc-
tor diagnosed asthma only (1,067 pedigrees). Again, no
chromosomal region with a p(SR) and p(OR) < 0.05 was
identified (data not shown).
Bronchial Hyper-responsiveness
The weighted BHR analyses strongly suggested that
6p22.3-p21.1 contains BHR susceptibility gene(s) as a
p(SR) and p(OR) < 0.05 was observed (p = 0.007, p =
0.049 respectively (Figure 1 and Table 3)). Two other
regions showed suggestive evidence (p < 0.0083) for link-
age to the BHR phenotype; 2p12-q22.1 (p(SR) = 0.006)
and 11q24.1-qter (p(SR) = 0.005). In the unweighted
analyses three regions showed evidence for linkage (p(SR)
and p(OR) ≤ 0.05), i.e. 2q22.1-q23.3, 7q12.11-q31.1 and
5q23.2-q34 (Figure 2).
Positive allergen skin prick test
Weighted analyses of the SPT phenotype identified two
regions that had a p(SR) and p(OR) ≤ 0.05 strongly sug-
gesting these regions are susceptibility loci (Figure 1 and
Table 4). These regions are 17p12-q24.3 (two adjacent
bins, 17p12-q21.33 p(SR) = 0.00043, p(OR) = 0.050 and
17q21.33-q24.3 p(SR) = 0.047, p(OR) = 0.038) and
region 3p22.1-q22.1 (three adjacent bins, 3p22.1-p14.1
p(SR) = 0.045, p(OR) = 0.063, 3p14.1-q12.3 p(SR) =
0.003, p(OR) = 0.0045 and 3q12.3-q22.1 p(SR) =
0.00084, p(OR) = 0.00406). The analyses of the
unweighted SPT datasets identified chromosomes 3 and
17 as containing the major determinants (Figure 2).
Total Immunoglobulin E
Weighted analyses of the IgE phenotype strongly sug-
gested 5q11.2-q14.3 (p(SR) = 0.031, p(OR) = 0.060) and
6pter-p22.3 (p(SR) = 0.033, p(OR) = 0.026) contain
genes that influence IgE levels (Figure 1 and Table 5). The
region adjacent to 6pter-p22.3, i.e. 6p22.3-p21.1 has a
p(SR) = 0.00999 approaching suggestive linkage provid-
ing further evidence for this region. Analyses of the IgER
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Table 1: Characteristics of genome-wide linkage studies included in the GSMA
NUMBER OF.(b)
COHORT (REF.) PHENOTYPES(a) PED. (AFF/IND.) MKS. WF. MKR MAP (SP.)(c) STUDY TYPE(d) ANALYSIS PROGRAM INCLUDED IN GSMA
Australian [9] B: Slope (-,0–12 μmol meth.) 80 (25/364) 253 142.267 - (10 cM) Nonpar.two. - B: 23 p-values < 0.05
I: Quantitative I: 21 p-values < 0.05
S: 2 allergens S: 19 p-values < 0.05
CSGA [33] A: Quest./Doc diag 79 (200/316) 360 168.642 Marshfield (10 cM) Nonpar. multi. Modified GENEHUNTER A: LOD scores from graphs
German [34] B: PD20 (Neb, < 8 mg/ml meth.) 97 (200/415) 333 179.725 Modified Genethon (10.7 cM) Nonpar. multi. GENEHUNTER, MAP-MAKER/SIBS B: Complete dataset
French [11] A: Quest./Meds. 46 (102/210) 254 108.093 – (13 cM) Nonpar. multi. GENEHUNTER, SIBPAIR A: 11 p-values
B: Slope (-, meth.) B: 8 p-values
I: Quantitative I: 8 p-values
S: 11 allergens S: 19 p-values
Icelandic [35] A: Doc diag./Meds. 175 (596/1134) 976* 413.280 Decode (4 cM) Nonpar. multi. ALLEGRO A: LOD scores from graphs
Dutch [10, 36, 37] A: Algorithm 200 (-/1159) 366 270.555 Marshfield Weber v8 (10 cM) Nonpar. SOLAR, GENEHUNTER A: Complete dataset
B: PD20 (-, < 32 mg/ml hist.) B: Complete dataset
I: Quantitative I: Complete dataset
S: 16 allergens S: Complete dataset
German [12] A: Doc diag. 201 (506/867) 364 270.489 Modified Genethon (10 cM) Nonpar. multi. MERLIN A: Complete dataset
I: Quantitative/Catagorical I: Complete quantitative dataset
S: HDM+ S: Complete dataset
Australian [13] A: Quest./Meds. 202 (169/591) 624 355.032 - (7.1 cM) Nonpar. multi. MERLIN, SOLAR A: Complete dataset
B: PD20 (-, < 7.8 μmol hist) B: Complete dataset
I: Quantitative I: Complete dataset
S: 11 allergens. S: Complete dataset
GAIN [16] A: Doc diag. 364 (1014/1555) 396* 379.663 Decode (-) Nonpar. multi. MERLIN A: LOD scores from graphs
B: PD20 (-, < 8 mg/ml meth.) B: LOD scores from graphs
S: 7 allergens S: LOD scores from graphs
(a) A = asthma; B = bronchial hyper-responsiveness (Neb = nebuliser, Dos = dosimeter); I = total serum IgE; S = skin prick test response; Quest = questionnaire; Doc diag = doctor diagnosis; Meds = 
asthma medication; Meth = methacholine; Hist = histamine; HDM = house dust mite; PD20 = provocation dose resulting in a 20% fall in FEV1. (b) Ped = total genotyped pedigrees; AFF = total genotyped 
asthmatic cases, Ind = total genotyped individuals; Mks = total autosomal microsatellite markers; Wt = weighting factor. (c) Sp = average marker spacing. (d) Nonpar = nonparametric; Two = two point; 
Multi = multipoint. (-) = not provided, *number of autosomal markers not given, total number used for weighting.Respiratory Research 2008, 9:38 http://respiratory-research.com/content/9/1/38
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phenotype using the unweighted GSMA showed similar
overall findings (Figure 2).
Multiple phenotype analyses
In addition to the primary phenotype analyses we investi-
gated overlapping chromosomal regions containing
genetic determinants of asthma and asthma related traits
consistent with gene(s) having pleiotrophic effects in
asthma and allergy (Table 6). Interestingly, region 6p22.3-
p21.1 which contains the HLA region showed a p(SR) <
0.05 in the asthma, BHR and IgE analyses potentially as
expected due to the role of HLA restriction in many immu-
nological mechanisms. Several other regions also showed
overlapping concordance, in particular regions; 3p14.1-
q12.3 (asthma, SPT), 5q23.2-q34 (asthma, BHR, IgE) and
7p21.1-14.1 (asthma, BHR, IgE).
Discussion
This study represents the first meta-analysis of asthma and
related trait linkage data using the majority of the data
available for the Caucasian asthma cohorts in the public
domain. This analysis combines data from 10 years of
asthma and atopy genetics and is extremely timely provid-
ing a definitive analysis of available linkage data to com-
plement the highly anticipated whole genome association
findings. Analysis of asthma and atopy quantitative traits
identified significant evidence for relatively few chromo-
somal regions as containing susceptibility gene(s) using
the most stringent genome-wide criteria i.e. BHR (6p22.3-
p21.1), total IgE (5q11.2-q14.3 and 6pter-p22.3) and
positive allergen skin prick test (3p22.1-q22.1, 17p12-
q24.3). Significantly no chromosomal region met strin-
gent genome-wide criteria in the asthma phenotype anal-
p(SR) & p(OR) in weighted GSMA Figure 1
p(SR) & p(OR) in weighted GSMA. A. asthma. B. bronchial hyper-responsiveness. C. total serum IgE. D. skin prick test 
response. A p(SR) of p < 0.000417 = significant linkage, p < 0.0083 = suggestive linkage. p(SR) & p(OR) data were transformed 
using f(x) = 0.05/x and plotted on a log10 scale to improve clarity.
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Table 2: Weighted GSMA for Asthma (1,267 pedigrees, n = 5,832)
PROBABILITY
BIN(a) GENETIC LOCUS(b) DISTANCE (cM)(c) PHYSICAL POSITION (KB)(d) SUMMED RANK (SR) p(SR) p(OR)
1 1pter-p36.23 0.00–20.61 pter-9332 376.576 0.68121 0.03775
5 1p31.1-p13.3 113.69–142.24 82867–110103 346.834 0.78259 0.00718*
8 1q31.1-q32 201.58–231.11 185232–210150 347.872 0.77937 0.02791
15 2p12-q22.1 101.56–128.41 79617–119705 341.174 0.79974 0.00694*
18 2q31.1-q34 177.53–206.74 172805–212021 317.985 0.86170 0.03548
20 2q35-qter 233.62–269.07 230618-qter 316.169 0.86603 0.00908
24 3p14.1-q12.3 88.60–117.76 64182–103187 612.921 0.02348 0.80059
31 4p14-q13.3 51.60–78.97 38279–72275 343.939 0.79152 0.00714*
34 4q28.3-q32.1 134.74–159.30 137492–160828 346.992 0.78212 0.01609
43 6pter-p22.3 0.00–32.62 pter-16854 383.747 0.65433 0.03220
44 6p22.3-p21.1 32.62–65.14 16854–43207 592.740 0.03905 0.72593
50 7p21.1-p14.1 29.28–59.93 19430–40230 317.779 0.86218 0.01583
53 7q31.1-q34 122.48–148.11 75216–138638 381.650 0.66230 0.03107
54 7q34-qter 148.11–181.97 138638-qter 313.741 0.87152 0.00536*
55 8pter-p22 0.00–27.40 pter-13111 376.368 0.68196 0.01899
59 8q22-q24.21 110.2–137.92 99237–127416 365.804 0.71999 0.02820
60 8q24.21-qter 137.92–167.90 127416-qter 373.141 0.69378 0.02636
62 9p22.3-p21.1 27.32–53.60 14264–29850 349.926 0.77291 0.03321
68 10p14-q11.21 29.15–62.23 10591–36230 635.659 0.01229 0.79026
75 11p12-q13.3 47.06–72.82 36450–70234 353.473 0.76155 0.02578
79 12pter-p12.1 0.00–24.45 pter-11686 299.278 0.90180 0.00570*
80 12p12.1-p11.21 24.45–53.28 11686–32879 292.228 0.91466 0.00766*
84 12q24.31-qter 139.61–170.60 120806-qter 607.388 0.02714 0.65821
87 13q22.2-q33.1 58.54–85.41 74875–102346 354.469 0.75831 0.04007
89 14pter-q13.1 0.00–40.11 pter- 33529 362.366 0.73182 0.03622
92 14q32.12-qter 105.00-138.18 90647-qter 305.539 0.88932 0.00423*
101 17pter-p12 0.00–25.14 pter-11325 312.768 0.87374 0.00213*
105 18pter-p11 0.00–24.08 pter- 7462 377.842 0.67650 0.04965
113 20pter-p12.3 0.00–21.15 pter-7608 339.111 0.80587 0.00524*
114 20p12.3-p11 21.15–47.52 7608–21259 282.935 0.92982 0.01324
Chromosomal regions with a p(SR) or p(OR) < 0.05 are shown. aBin number from GSMA (1–120 inclusive). bCytogenetic band (Taken from April 
2002 Genome Browser, UCSC). cGenetic distance in Marshfield cM (not cumulative). dPhysical position in kilobase pairs (Taken from December 
2006 UniSTS, NCBI/Genome Browser, UCSC). *p < 0.000417 = Genome wide significance for linkage, p < 0.0083 = Suggestive for linkage [5].
Table 4: Weighted GSMA for skin prick test response (1,093 pedigrees, n = 4,746)
PROBABILITY
BIN(a) GENETIC LOCUS(b) DIST. (cM)(c) PHYS POS. (KB)(d) SUMMED RANK (SR) p(SR) p(OR)
6 1p13.3-q23.3 142.24–170.84 110103–159125 541.271 0.02081 0.22906
23 3p22.1-p14.1 63.12–88.60 38845–64182 513.869 0.04488 0.06344
24 3p14.1-q12.3 88.60–117.76 64182–103187 591.392 0.00298* 0.00450
25 3q12.3-q22.1 117.76–146.60 103187–134474 614.373 0.00084* 0.00406
45 6p21.1-q15 65.14–99.01 43207–90985 521.717 0.03654 0.12598
46 6q15-q23.2 99.01–131.07 90985–132584 525.276 0.03318 0.18839
77 11q22.3-q24.1 98.98–123.00 103732–122977 515.746 0.04276 0.11460
102 17p12-q21.33 25.14–63.62 11325–39726 624.777 0.00043* 0.05044
103 17q21.33-q24.3 63.62–93.98 39726–66600 511.187 0.04799 0.03824
108 18q22.1-qter 96.48–126.00 60025-qter 209.839 0.96132 0.03480
118 21q21.3-qter 25.26–57.77 27903-qter 528.536 0.03029 0.28738
Chromosomal regions with a p(SR) or p(OR) < 0.05 are shown. aBin number from GSMA (1–120 inclusive). bCytogenetic band (Taken from April 
2002 Genome Browser, UCSC). cGenetic distance in Marshfield cM (not cumulative). dPhysical position in kilobase pairs (Taken from December 
2006 UniSTS, NCBI/Genome Browser, UCSC). *p < 0.000417 = Genome wide significance for linkage, p < 0.0083 = Suggestive for linkage [5].Respiratory Research 2008, 9:38 http://respiratory-research.com/content/9/1/38
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yses. This study did provide supporting evidence for
regions containing previously identified asthma suscepti-
bility genes.
Linkage analyses has proven to be highly successful in sin-
gle gene disorders e.g. cystic fibrosis but has been prob-
lematic in asthma and atopy mainly due to the complex
genetic basis of these phenotypes and the use of inade-
quate samples sizes leading to both type I and type II
errors. In the current study we aimed to combine all avail-
able linkage data for asthma and related trait phenotypes
(BHR, total IgE, positive allergen skin prick test) and pro-
vide inferences about the consistency of results across
studies, ultimately providing a focus for future gene dis-
covery. The analyses of the quantitative traits provided the
most significant findings and may be consistent with the
observation that using objective markers of disease adds
to the homogeneity of the data and may improve results.
In addition the number of genes regulating these pheno-
types may be smaller than "asthma" and power to find
these may be increased.
This study strongly suggested that regions 17p12-q21.33
and 3p14.1q22.1 contain gene(s) that influence allergen
skin prick responses and by inference atopy. Both of these
regions are large spanning 28.5 and 70.3 Mbp respec-
tively. The 3p21 region has been identified as containing
genetic determinants of specific allergen responses in the
Hutterite founder asthma cohort [22] and has been iden-
tified as an atopic dermatitis locus (3p24-22) [23]. Link-
age to chromosome 17 and specific allergen responses has
been described in the Hutterite population however these
p(SR) & p(OR) in unweighted GSMA Figure 2
p(SR) & p(OR) in unweighted GSMA. A. asthma. B. bronchial hyper-responsiveness. C. total serum IgE. D. skin prick test 
response. A p(SR) of p < 0.000417 = significant linkage, p < 0.0083 = suggestive linkage. p(SR) & p(OR) data were transformed 
using f(x) = 0.05/x and plotted on a log10 scale to improve clarity.
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linkages map to 17q25 in asthma [22]. Linkage to atopic
dermatitis on 17q23.1 has been reported [23]. Also of sig-
nificance is the fact that the chromosome 17 locus
(17p12-q21.33) identified in the current analyses con-
tains the recently identified ORMDL3 gene [24]. Using
whole genome association variants in the ORMDL3 gene
were shown to be associated with childhood onset asthma
[24]. Overall our data suggest that the major genes influ-
encing allergen skin prick responses are found on chro-
mosomes 3 and 17.
In the total IgE analyses there was strong evidence for the
presence of genes(s) regulating IgE production in the
5q11.2-q14.3 and 6pter-p21.1 regions. This region on
chromosome 6 contains the Human Leukocyte Antigen
(HLA) locus and so may be predicted to contain determi-
nants of immunological processes. The finding that
5q11.2-q14.3 may contain gene(s) that influence IgE pro-
duction is novel and warrants further investigation. The
IgE analyses also confirmed the potential contribution of
genes within the 5q23.2-q34 and 11q13.3-q22.3 regions
that have previously been suggested [25]. Interestingly, of
the four positionally cloned genes identified using IgE as
a key phenotype only the region encompassing the GPRA
gene showed limited (non significant) linkage (7p21.1-
p14.1, p(SR) = 0.027).
In the BHR analyses the 6p22.3-p21.1 region was identi-
fied as containing susceptibility gene(s). This region con-
tains the HLA locus and the HLA-G gene within this
Table 3: Weighted GSMA for bronchial hyper-responsiveness (989 pedigrees, n = 4,294)
PROBABILITY
BIN(a) GENETIC LOCUS(b) DISTANCE (cM)(c) PHYSICAL POSITION (KB)(d) SUMMED RANK (SR) p(SR) p(OR)
14 2p16.2-p12 76.34–101.56 54063–79617 532.855 0.02751 0.22094
15 2p12-q22.1 101.56–128.41 79617–119705 576.585 0.00574* 0.14743
16 2q22.1-q23.3 128.41–154.48 119705–151529 518.593 0.04085 0.08859
41 5q23.2-q34 131.48–164.19 123774–162087 551.701 0.01511 0.09586
44 6p22.3-p21.1 32.62–65.14 16854–43207 571.381 0.00716* 0.04861
50 7p21.1-p14.1 29.28–59.93 19430–40230 523.367 0.03597 0.24658
51 7p14.1-q21.11 59.93–91.67 40230–81002 518.746 0.04070 0.19114
52 7q21.11-q31.1 91.67–122.48 81002–109766 461.380 0.13926 0.02065
58 8q13.1-q22 82.84–110.20 67744–99237 468.188 0.12312 0.04443
76 11q13.3-q22.3 72.82–98.98 70185–103732 465.589 0.12913 0.01652
78 11q24.1-qter 123.00–147.77 122977-qter 579.520 0.00505* 0.46485
86 13q13.2-q22.2 26.87–58.54 33636–74875 472.999 0.11255 0.03312
111 19q12-q13.33 52.59–75.41 35843–54589 460.759 0.14078 0.01070
115 20p11-q13.13 47.52–72.27 21259–46747 476.308 0.10563 0.03503
116 20q13.13-qter 72.27–101.22 46747-qter 467.593 0.12448 0.02343
Chromosomal regions with a p(SR) or p(OR) < 0.05 are shown. aBin number from GSMA (1–120 inclusive). bCytogenetic band (Taken from April 
2002 Genome Browser, UCSC). cGenetic distance in Marshfield cM (not cumulative). dPhysical position in kilobase pairs (Taken from December 
2006 UniSTS, NCBI/Genome Browser, UCSC). *p < 0.000417 = Genome wide significance for linkage, p < 0.0083 = Suggestive for linkage [5].
Table 5: Weighted GSMA for total serum IgE (729 pedigrees, n = 3,224)
PROBABILITY
BIN(a) GENETIC LOCUS(b) DIST. (cM)(c) PHYS POS. (KB)(d) SUMMED RANK (SR) p(SR) p(OR)
2 1p36.23-p35.3 20.61–54.30 9332 – 24723 476.251 0.01171 0.41867
7 1q23.3-q31.1 170.84–201.58 159125–185232 450.659 0.03099 0.14664
39 5q11.2-q14.3 64.14–97.82 55758–88765 450.303 0.03127 0.06031
41 5q23.2-q34 131.48–164.19 123774–162087 464.611 0.01890 0.40276
43 6pter-p22.3 0.00–32.62 pter-16854 448.903 0.03276 0.02583
44 6p22.3-p21.1 32.62–65.14 16854–43207 479.723 0.00999 0.71984
50 7p21.1-p14.1 29.28–59.93 19430–40230 454.706 0.02708 0.41494
76 11q13.3-q22.3 72.82–98.98 70185–103732 453.763 0.02792 0.22926
Chromosomal regions with a p(SR) or p(OR) < 0.05 are shown. aBin number from GSMA (1–120 inclusive). bCytogenetic band (Taken from April 
2002 Genome Browser, UCSC). cGenetic distance in Marshfield cM (not cumulative). dPhysical position in kilobase pairs (Taken from December 
2006 UniSTS, NCBI/Genome Browser, UCSC). *p < 0.000417 = Genome wide significance for linkage, p < 0.0083 = Suggestive for linkage [5].Respiratory Research 2008, 9:38 http://respiratory-research.com/content/9/1/38
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region has previously been identified as a potential
asthma and BHR susceptibility gene using four cohorts
(including the Dutch cohort used in the current analyses)
[26]. Our data confirms this region as a BHR locus and
less significantly a potential asthma locus (p(SR) =
0.039). Interestingly, four of the six populations used for
the BHR analyses ranked the chromosome 2p locus iden-
tified in the top 33% of bins including the Genetics of
Asthma International Network (GAIN) study (data not
shown). Further mapping of the 2p locus in the GAIN
population using single nucleotide polymorphisms
(SNP) spanning the region refined the linkage peak to ~70
cM with the greatest evidence being for the BHR pheno-
type (LOD score 4.58) [16]. Region 2p12-q22.1 contains
the DPP10 gene that has previously been identified as an
asthma and total IgE susceptibility gene [27] and the
IL1RN gene identified using asthma as the primary phe-
notype [28]. The identification of 11q24.1-qter as a
potential BHR susceptibility locus appears to be novel and
therefore these data may provide a platform for novel
BHR susceptibility gene identification. The BHR analyses
also confirmed the potentially modest contribution of
other loci in determining the BHR phenotype including
e.g. 5q23.2-q34 and 19q12-q13.33. In the analyses of the
BHR phenotype significant linkage was not driven by
studies using a specific agonist i.e. studies using both
methacholine and histamine provocation contributed to
the signal at a specific locus (data not shown). These data
suggest responsiveness to these agents share a common
genetic basis and provide support for combining studies
in the meta-analyses using these different provocation
stimuli.
Significantly, using asthma as a phenotype we did not
identify any chromosomal region as showing genome-
wide significance in our analyses. In most studies, asthma
was defined as a doctor's diagnosis. In the Dutch study,
families were ascertained through a proband with a doc-
tor's diagnosis of asthma. In the offspring of these asthma
patients, an algorithm was used since a doctor's diagnosis
per se underestimated the prevalence of asthma in the off-
spring [8]. To confirm that the inclusion of the Dutch
linkage data for the asthma phenotype had not con-
founded the analyses we completed GSMA without these
data and again no chromosomal region with a p(SR) and
p(OR) < 0.05 was identified (data not shown). These data
may reflect the true locus heterogeneity in asthma or
reflect differences in phenotype definition when compar-
Table 6: Overlapping chromosomal regions in weighted GSMA for asthma, and the three intermediate phenotypes
ASTHMA BHR TOTAL IGE SPT RESPONSE
BIN(a) GENETIC 
LOCUS(b)
DIST. (cM)(c) PHYS POS. 
(KBp)(d)
p(SR) p(OR) p(SR) p(OR) p(SR) p(OR) p(SR) p(OR)
6 1p13.3-q23.3 142.24–170.84 110103–159125 - - - - 0.06630 0.13155 0.02081 0.22906
7 1q23.3-q31.1 170.84–201.58 159125–185232 - - - - 0.03099 0.14664 0.08924 0.13402
15 2p12-q22.1 101.56–128.41 79617–119705 0.79974 0.00694 0.00574* 0.14743 - - - -
24 3p14.1-q12.3 88.60–117.76 64182–103187 0.02348 0.80059 0.09312 0.17837 - - 0.00298 0.00450*
40 5q5q14.3-q23.2 97.82–131.48 88765–123774 0.71879 0.05004 - - 0.09195 0.08596 - -
41 5q23.2-q34 131.48–164.19 123774–162087 0.06027 0.77886 0.01511 0.09586 0.01890 0.40276 - -
43 6pter-p22.3 0.00–32.62 pter-16854 0.65433 0.03220 - - 0.03276 0.02583 - -
44 6p22.3-p21.1 32.62–65.14 16854–43207 0.03905 0.72593 0.00716* 0.04861 0.00999 0.71984 0.09934 0.16043
45 6p21.1-q15 65.14–99.01 43207–90985 - - 0.07128 0.19832 - - 0.03654 0.12598
46 6q15-q23.2 99.01–131.07 90985–132584 - - 0.09445 0.10925 - - 0.03318 0.18839
50 7p21.1-p14.1 29.28–59.93 19430–40230 0.86218 0.01583 0.03597 0.24658 0.02708 0.41494 - -
55 8pter-p22 0.00–27.40 pter-13111 0.68196 0.01899 - - - - 0.06027 0.07341
71 10q23.33-
q26.13
117.42–142.78 95985–123274 0.85805 0.05664 0.16985 0.08106 - - - -
76 11q13.3-q22.3 72.82–98.98 70185–103732 - - 0.12913 0.01652 0.02792 0.22926 - -
77 11q22.3-q24.1 98.98–123.00 103732–122977 - - - - 0.08890 0.12887 0.04276 0.11460
78 11q24.1-qter 123.00–147.77 122977-qter - - 0.00505* 0.46485 - - 0.08072 0.12542
84 12q24.31-qter 139.61–170.60 120806-qter 0.02714 0.65821 - - 0.07175 0.10909 - -
85 13pter-q13.2 0.00–26.87 pter-33636 - - 0.05521 0.18686 0.08835 0.22042 - -
92 14q32.12-qter 105.00–138.18 90647-qter 0.88932 0.00423* - - - - 0.95708 0.07887
108 18q22.1-qter 96.48–126.00 60025-qter - - 0.08190 0.24216 - - 0.96132 0.03480
115 20p11-q13.13 47.52–72.27 21259–46747 0.65424 0.06184 0.10563 0.03503 - - - -
118 21q21.3-qter 25.26–57.77 27903-qter - - 0.20402 0.09140 - - 0.03029 0.28738
Chromosomal regions with p(SR) or p(OR) < 0.1 in two or more weighted GSMA are shown. aBin number from GSMA (1–120 inclusive). 
bCytogenetic band (Taken from April 2002 Genome Browser, UCSC). cGenetic distance in Marshfield cM (not cumulative). dPhysical position in 
kilobase pairs (Taken from December 2006 UniSTS, NCBI/Genome Browser, UCSC). *p < 0.000417 = Genome wide significance for linkage, p < 
0.0083 = Suggestive for linkage.Respiratory Research 2008, 9:38 http://respiratory-research.com/content/9/1/38
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ing asthma based on doctors' diagnosis over different
cohorts. In addition the use if a binary trait i.e. affection
will have the lowest intrinsic power compared to contin-
ual data e.g. IgE levels.
Interestingly, the recently published whole genome asso-
ciation study using 994 asthmatic children and 1,243 non
asthmatic children identified only 16 SNPs (eight on
chromosome 17) from a total of 317,447 SNPs tested
showing a significant association with asthma per se (5%
false discovery threshold, stratification corrected) [24].
This study complements our analysis using data from
1,257 families and taken together suggests that the use of
asthma as a phenotype may be confounded due to locus
heterogeneity in asthma and/or issues concerning pheno-
type definition/heterogeneity when combining cohorts. It
is important to note that the family based studies
included in this meta-analyses address the genetic basis of
asthma defined in children i.e. the mean age of siblings in
most studies is < 16 years.
Several regions showed suggestive evidence for linkage to
the asthma phenotype mainly based on the p(OR) statis-
tic, however caution should be taken interpreting p(OR)
in isolation, especially in the presence of incomplete data
sets [5]. Further evidence for the chromosome 12 and 20
loci comes from the finding that adjacent bins have a
p(OR) < 0.05 suggesting the linkage is spanning the bin
interval. 4/6 regions containing the positionally cloned
asthma susceptibility genes i.e. ADAM33 (20p13[7]),
PHF11  (13q14.3 [29]), DPP10  (2q14.1 [27]), HLAG
(6p21.3 [26]), GPRA (7p14.3 [30]), IL1RN (2q13 [28])
and the recently reported gene ORMDL3  (17q12-
q21[24]) were identified by the GSMA approach,
ADAM33 (p(OR) = 0.005), DPP10 and IL1RN (p(OR) =
0.007) and less significantly HLA-G (p(SR) = 0.039) and
GRPA (p(OR) = 0.031). In addition our data also suggests
that further investigation of additional chromosomal
regions may be productive e.g. 1p31.1-p13.3 and
14q32.12-qter. Recently, the 1p31 and 14q32 regions
have been highlighted as potential asthma loci in a French
cohort with data suggesting 1p31 may contain gene(s) of
importance to asthma and atopic dermatitis co morbidity
and the 14q32 locus may interact with smoking exposure
and contain asthma susceptibility gene(s) [31,32].
The analysis of overlap between chromosomal regions
confirmed the importance of the HLA locus on chromo-
some 6 as being a key susceptibility locus in asthma and
also highlighted other regions that may be of importance
i.e. 5q23.2-q34 and 7p21.1-14.1. The 5q23.2-q34 region
contains the cytokine gene cluster (IL4, Il13, IL5, IL12B)
and has previously been suggested as an asthma/atopy
susceptibility locus [3] and the 7p21.1-14.1 region con-
tains the previously identified asthma susceptibility gene,
GPRA (7p14.3) [30].
In conclusion, we present the first systematic meta-analy-
ses of asthma and related trait linkage data in the Cauca-
sian population. These data are based on the majority of
the data available in the public domain (or through col-
laboration) therefore we do not consider that exclusion or
missing data for other populations has biased our analy-
ses. While the GSMA method has limitations e.g. only
large chromosomal regions can be identified, these analy-
ses have determined the role of several previously identi-
fied susceptibility loci and highlighted the significance of
regions not previously implicated in asthma and atopy
susceptibility. Importantly, this study also highlighted the
limitations of using asthma as a phenotype in contrast to
quantitative traits even with the increased power of 1,267
families composed of 5,832 individuals. Finally, these
data will provide useful guidance for the interpretation of
the anticipated genome wide association analyses in
asthma and atopy.
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